Twitter Beğeni Hilesi

The MOGA 2024 Breast Cancer Preceptorship will take place over 1.5 days on Fri 18 - Sat 19 October in Sydney! Registrations are open and we are still seeking EOIs from Preceptors. Travel support is available. moga.org.au/breast-precept…

Don't forget to join us at #ESMO24 next Friday 2pm for an exciting session on ESMO-MCBS. ESMO - Eur. Oncology

Have you expressed your interest in the 2024 Lung Cancer Preceptorship? Registrations closing October 1. Date: 22 - 23 November 2024 Location: Brisbane Find out more > buff.ly/3MkapUG

I might have missed it but did those with PD-L1 1-49% get chemotherapy in the ivonescimab vs pembro trial? A little bit problematic if not? #WCLC24

HARMONi-2: striking PFS results. Ivonescimab appears efficacious..but... Patients with PD-L1 1-49% were subject to an inferior control arm. SOC is pembro AND chemo. And I know it's hard but wouldn't it be wonderful if OS was the primary endpoint #WCLC24 Common Sense Oncology

In case you’re wondering about ADOPT trial: etop.ibcsg.org/projects/clini…

Dr Lauren B after her amazing oral presentation on the use of RT to treat oligoprogressing/resistant NSCLC. Her mentors myself and Adnan Nagrial were too engrossed in her talk to take a photo during it! #WCLC24 IASLC

Following presentation at #WCLC2024 our publication on radiotherapy in oligoprogrogression in NSCLC following 1L ICIs is out in JTO & JTO CRR #jtocrr Adnan Nagrial Inês Pires da Silva Harriet Gee Eric Hau jtocrr.org/article/S2666-…

All trainees and early fellows.....if you sign up to Thoracic Oncology Group of Australasia lung cancer preceptorship, you will get an opportunity to be mentored by this serious-looking oncologist bit.ly/4d65UZa

San Diego nights with the Aussie crew 🌆✨🇦🇺#WCLC24

Team Australia at #WCLC2024 IASLC Dr Deme Karikios Adnan Nagrial Venessa Chin Victoria Bray Dasantha Jayamanne | DJ | Prunella Blinman Miriam Boxer Lauren B Tongles Melissa Moore So wonderful being with such amazing colleagues !

Fantastic discussion by Prof Chee Lee of two early phase trials targeting HER-2 mutated lung cancer Great response rates& appear very safe for both but he reminds us that multiple grade 1 toxicities aren't always perceived as "tolerable" by those that take the drugs #WCLC24

Lovely to see Hidehito HORINOUCHI earlier and now hearing him talk about the ALINA trial (safety results) Ben Solomon #WCLC24

Important study, but let’s not forget that this is still an exploratory post hoc analysis. The correct way to answer this question is to compare periop versus neoadj head to head. Looking forward to results of these trials.

Pleased that IASLC is holding a session on #financialtoxicity which we know is associated with poorer outcomes. And chaired by Thoracic Oncology Group of Australasia's own Angeline Low! #WCLC24

Great talk by Dr Anne-Marie Baird at #WCLC24 on financial toxicity in lung cancer. Good to see thought going into solutions as well like the work of the COSA financial toxicity working group. cosa.org.au/media/idtdw2zk…

It’s time for the second annual class of CSO Fellows! Calling all early career medical oncologists! Now accepting applications for the Common Sense Oncology Fellowship in Cancer Policy Queen's University. Apply today to help build a better cancer care system. Read the full posting

SIMULTANEOUS PUBLICATION ALERT!🚨 As I mentioned in my talk, a comprehensive review answering most frequently asked questions on surrogate endpoints in oncology has been simultaneously published in eClinicalMedicine – The Lancet Discovery Science today with our ESMO - Eur. Oncology MCBS session. OPEN ACCESS.

Selfie with the Common Sense Oncology organizers and and @asco folks Bishal Gyawali Julie Gralow Lynn Schuchter at #ESMO24 The local hosts kindly offered me a ride to the nearest metro😘